OraSure Technologies, Inc. Announces Purchase of UrSure, Inc. (May 2020)
OraSure Technologies, Inc., a leader in point of care diagnostic tests and specimen collection and stabilization devices, and microbiome laboratory and analytical services, today announced that it has entered into a definitive agreement to acquire privately owned UrSure, Inc. for cash.
Channel 2 Atlanta:
UrSure's Point of Care Tenofovir Adherence Test
HIV Prevention Startup Concludes Research Study with DC Dept of Health (February 2020)
According to Dr. Adam Visconti, the CMO of the HIV/AIDS, Hepatitis, STD, and TB admin, “the tests led the clinical staff at the clinic to discuss adherence more routinely as a clinic, and made their approach to managing adherence more quantitative.”
UrSure Ships World’s First Point of Care Adherence Test for Researchers (January 2020)
UrSure, an HIV prevention company, today announced that the company has shipped the first order of their novel Point of Care PrEP adherence test to a domestic researcher.
Clinics in 10 States have Adopted UrSure's PrEP Adherence Test (November 2019)
Harvard spinoff has sold more than 4,000 tests to improve HIV care for vulnerable patients.
Midland Medical Center Reports Almost 90% PrEP Adherence with Revamped Protocol (October 2019)
With the President's Advisory Council on HIV/AIDS meeting in Miami in October, Oakland Park's Midland Medical demonstrates promising results from innovative PrEP program.